| ID/Version |
|
||||||||||||||
|
Sequence description from provider |
RecName: Full=Early activation antigen CD69;AltName: CD_antigen=CD69; | ||||||||||||||
| Provider | SWISS-PROT | ||||||||||||||
| Sequence |
Polypeptide
199
aa
|
||||||||||||||
| Source | |||||||||||||||
| Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
| Sequence references in MGI |
J:42341
Ziegler SF, et al., Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J Immunol. 1993 Jul;23(7):1643-8
J:107152 Shiow LR, et al., CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature. 2006 Mar 23;440(7083):540-4 J:372165 Martin P, et al., CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation. Mol Cell Biol. 2010 Oct;30(20):4877-89 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 10/07/2025 MGI 6.24 |
|
|
|
||